Comparative evaluation of simple indices of graft function after islet transplantation

Andrea Caumo, Paola Maffi, Rita Nano, Livio Luzi, Robert Hilbrands, Pieter Gillard, Daniel Jacobs-Tulleneers-Thevissen, Antonio Secchi, Bart Keymeulen, Daniel Pipeleers, Lorenzo Piemonti

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background.: Several simple measures of graft function after islet transplantation have been proposed but a comparative evaluation is lacking. Here, we compared the performance of five indices of β-cell function: β-score, transplant estimated function (TEF), homeostasis model assessment (HOMA) 2-B%, C-peptide/glucose ratio, and Secretory Units of Islets in Transplantation (SUIT). Methods.: Two cohorts of transplanted patients were analyzed. Cohort 1 consisted of 14 recipients with type 1 diabetes of islet transplantation whereas cohort 2 consisted of 21 recipients with type 1 diabetes of cultured islet cell graft. The five surrogate indices were compared against the first-and second-phase insulin response to arginine in cohort 1, and against the C-peptide response to a hyperglycemic clamp in cohort 2. Results.: We found that the performances of the five surrogate indices were close one to each other in cohort 1. The correlation coefficients ranged 0.62 to 0.67 and 0.62 to 0.68 against the first-and second-phase insulin response to arginine, respectively. In cohort 2, we found that the β-score, TEF, C-peptide/glucose ratio, and SUIT were reasonably well correlated with the clamp response (correlation coefficients were in the range 0.71-0.81), whereas HOMA2-B% showed a modest performance (r=0.54). HOMA2-B% could not be evaluated in one patient whose fasting glucose concentration level was below the lower bound indicated by the HOMA calculator (3 mmol/L). SUIT could not be evaluated in three patients whose fasting glucose concentration was below the glucose threshold of the SUIT formula (3.43 mmol/L). Conclusion.: In summary, no single index ouperformed the others. Nevertheless, when the benefit to cost ratio is considered, TEF stands out for its good performance at a very low cost.

Original languageEnglish
Pages (from-to)815-821
Number of pages7
JournalTransplantation
Volume92
Issue number7
DOIs
Publication statusPublished - Oct 15 2011

Fingerprint

Islets of Langerhans Transplantation
Transplants
C-Peptide
Glucose
Type 1 Diabetes Mellitus
Arginine
Fasting
Homeostasis
Insulin
Islets of Langerhans
Cost-Benefit Analysis
Cultured Cells
Costs and Cost Analysis

Keywords

  • Insulin secretion
  • Islet transplantation
  • Modeling

ASJC Scopus subject areas

  • Transplantation

Cite this

Comparative evaluation of simple indices of graft function after islet transplantation. / Caumo, Andrea; Maffi, Paola; Nano, Rita; Luzi, Livio; Hilbrands, Robert; Gillard, Pieter; Jacobs-Tulleneers-Thevissen, Daniel; Secchi, Antonio; Keymeulen, Bart; Pipeleers, Daniel; Piemonti, Lorenzo.

In: Transplantation, Vol. 92, No. 7, 15.10.2011, p. 815-821.

Research output: Contribution to journalArticle

Caumo, A, Maffi, P, Nano, R, Luzi, L, Hilbrands, R, Gillard, P, Jacobs-Tulleneers-Thevissen, D, Secchi, A, Keymeulen, B, Pipeleers, D & Piemonti, L 2011, 'Comparative evaluation of simple indices of graft function after islet transplantation', Transplantation, vol. 92, no. 7, pp. 815-821. https://doi.org/10.1097/TP.0b013e31822ca79b
Caumo, Andrea ; Maffi, Paola ; Nano, Rita ; Luzi, Livio ; Hilbrands, Robert ; Gillard, Pieter ; Jacobs-Tulleneers-Thevissen, Daniel ; Secchi, Antonio ; Keymeulen, Bart ; Pipeleers, Daniel ; Piemonti, Lorenzo. / Comparative evaluation of simple indices of graft function after islet transplantation. In: Transplantation. 2011 ; Vol. 92, No. 7. pp. 815-821.
@article{436887be589f4037bb09a732103bfe98,
title = "Comparative evaluation of simple indices of graft function after islet transplantation",
abstract = "Background.: Several simple measures of graft function after islet transplantation have been proposed but a comparative evaluation is lacking. Here, we compared the performance of five indices of β-cell function: β-score, transplant estimated function (TEF), homeostasis model assessment (HOMA) 2-B{\%}, C-peptide/glucose ratio, and Secretory Units of Islets in Transplantation (SUIT). Methods.: Two cohorts of transplanted patients were analyzed. Cohort 1 consisted of 14 recipients with type 1 diabetes of islet transplantation whereas cohort 2 consisted of 21 recipients with type 1 diabetes of cultured islet cell graft. The five surrogate indices were compared against the first-and second-phase insulin response to arginine in cohort 1, and against the C-peptide response to a hyperglycemic clamp in cohort 2. Results.: We found that the performances of the five surrogate indices were close one to each other in cohort 1. The correlation coefficients ranged 0.62 to 0.67 and 0.62 to 0.68 against the first-and second-phase insulin response to arginine, respectively. In cohort 2, we found that the β-score, TEF, C-peptide/glucose ratio, and SUIT were reasonably well correlated with the clamp response (correlation coefficients were in the range 0.71-0.81), whereas HOMA2-B{\%} showed a modest performance (r=0.54). HOMA2-B{\%} could not be evaluated in one patient whose fasting glucose concentration level was below the lower bound indicated by the HOMA calculator (3 mmol/L). SUIT could not be evaluated in three patients whose fasting glucose concentration was below the glucose threshold of the SUIT formula (3.43 mmol/L). Conclusion.: In summary, no single index ouperformed the others. Nevertheless, when the benefit to cost ratio is considered, TEF stands out for its good performance at a very low cost.",
keywords = "Insulin secretion, Islet transplantation, Modeling",
author = "Andrea Caumo and Paola Maffi and Rita Nano and Livio Luzi and Robert Hilbrands and Pieter Gillard and Daniel Jacobs-Tulleneers-Thevissen and Antonio Secchi and Bart Keymeulen and Daniel Pipeleers and Lorenzo Piemonti",
year = "2011",
month = "10",
day = "15",
doi = "10.1097/TP.0b013e31822ca79b",
language = "English",
volume = "92",
pages = "815--821",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Comparative evaluation of simple indices of graft function after islet transplantation

AU - Caumo, Andrea

AU - Maffi, Paola

AU - Nano, Rita

AU - Luzi, Livio

AU - Hilbrands, Robert

AU - Gillard, Pieter

AU - Jacobs-Tulleneers-Thevissen, Daniel

AU - Secchi, Antonio

AU - Keymeulen, Bart

AU - Pipeleers, Daniel

AU - Piemonti, Lorenzo

PY - 2011/10/15

Y1 - 2011/10/15

N2 - Background.: Several simple measures of graft function after islet transplantation have been proposed but a comparative evaluation is lacking. Here, we compared the performance of five indices of β-cell function: β-score, transplant estimated function (TEF), homeostasis model assessment (HOMA) 2-B%, C-peptide/glucose ratio, and Secretory Units of Islets in Transplantation (SUIT). Methods.: Two cohorts of transplanted patients were analyzed. Cohort 1 consisted of 14 recipients with type 1 diabetes of islet transplantation whereas cohort 2 consisted of 21 recipients with type 1 diabetes of cultured islet cell graft. The five surrogate indices were compared against the first-and second-phase insulin response to arginine in cohort 1, and against the C-peptide response to a hyperglycemic clamp in cohort 2. Results.: We found that the performances of the five surrogate indices were close one to each other in cohort 1. The correlation coefficients ranged 0.62 to 0.67 and 0.62 to 0.68 against the first-and second-phase insulin response to arginine, respectively. In cohort 2, we found that the β-score, TEF, C-peptide/glucose ratio, and SUIT were reasonably well correlated with the clamp response (correlation coefficients were in the range 0.71-0.81), whereas HOMA2-B% showed a modest performance (r=0.54). HOMA2-B% could not be evaluated in one patient whose fasting glucose concentration level was below the lower bound indicated by the HOMA calculator (3 mmol/L). SUIT could not be evaluated in three patients whose fasting glucose concentration was below the glucose threshold of the SUIT formula (3.43 mmol/L). Conclusion.: In summary, no single index ouperformed the others. Nevertheless, when the benefit to cost ratio is considered, TEF stands out for its good performance at a very low cost.

AB - Background.: Several simple measures of graft function after islet transplantation have been proposed but a comparative evaluation is lacking. Here, we compared the performance of five indices of β-cell function: β-score, transplant estimated function (TEF), homeostasis model assessment (HOMA) 2-B%, C-peptide/glucose ratio, and Secretory Units of Islets in Transplantation (SUIT). Methods.: Two cohorts of transplanted patients were analyzed. Cohort 1 consisted of 14 recipients with type 1 diabetes of islet transplantation whereas cohort 2 consisted of 21 recipients with type 1 diabetes of cultured islet cell graft. The five surrogate indices were compared against the first-and second-phase insulin response to arginine in cohort 1, and against the C-peptide response to a hyperglycemic clamp in cohort 2. Results.: We found that the performances of the five surrogate indices were close one to each other in cohort 1. The correlation coefficients ranged 0.62 to 0.67 and 0.62 to 0.68 against the first-and second-phase insulin response to arginine, respectively. In cohort 2, we found that the β-score, TEF, C-peptide/glucose ratio, and SUIT were reasonably well correlated with the clamp response (correlation coefficients were in the range 0.71-0.81), whereas HOMA2-B% showed a modest performance (r=0.54). HOMA2-B% could not be evaluated in one patient whose fasting glucose concentration level was below the lower bound indicated by the HOMA calculator (3 mmol/L). SUIT could not be evaluated in three patients whose fasting glucose concentration was below the glucose threshold of the SUIT formula (3.43 mmol/L). Conclusion.: In summary, no single index ouperformed the others. Nevertheless, when the benefit to cost ratio is considered, TEF stands out for its good performance at a very low cost.

KW - Insulin secretion

KW - Islet transplantation

KW - Modeling

UR - http://www.scopus.com/inward/record.url?scp=81155162614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155162614&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31822ca79b

DO - 10.1097/TP.0b013e31822ca79b

M3 - Article

C2 - 21836536

AN - SCOPUS:81155162614

VL - 92

SP - 815

EP - 821

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 7

ER -